Article Data

  • Views 592
  • Dowloads 80

Original Research

Open Access

The Physical Symptom Scale-8: Psychometric Characteristics of a Short-Form Version of the PHQ-15 and its Use in TMD-Related Assessment and Research

  • Adrian Ujin Yap1,2
  • Darren Zong Ru Lee2
  • Sharon Hui Xuan Tan3,4,*,

1Department of Dentistry, Ng Teng Fong General Hospital and Faculty of Dentistry, National University Health System, Singapore

2National Dental Research Institute, Singapore, National Dental Centre Singapore, and Duke-NUS Medical School, Singapore Health Services, School of Health and Social Sciences Nanyang Polytechnic, Singapore

3School of Health and Social Sciences Nanyang Polytechnic, Singapore

4Saw See Hock School of Public Health National University of Singapore, Singapore

5School of Health and Social Sciences Nanyang Polytechnic, Singapore

DOI: 10.11607/ofph.3187 Vol.37,Issue 3,September 2023 pp.159-165

Submitted: 18 February 2022 Accepted: 10 December 2022

Published: 30 September 2023

*Corresponding Author(s): Sharon Hui Xuan Tan E-mail: thxsharon@gmail.com

Abstract

Aims: To describe the development of the Physical Symptom Scale-8 (PSS-8) and to examine its psychometric properties and use in temporomandibular disorder (TMD)–related assessment and research. Methods: An online survey comprising demographic variables, the DC/TMD pain screener (TPS), Short-Form Fonseca Anamnestic Index (SFAI), PSS-8, PHQ-15, and Depression, Anxiety, and Stress Scale-21 (DASS-21) was administered to young adults attending a technical college. The PSS-8 adopted the Somatic Symptom Scale-8 (SSS-8) items but maintained the 3-point response scale and 4-week time frame of the PHQ-15. Internal consistency and reliability of the PSS-8 were determined by its Cronbach α value. Known-groups and concurrent/convergent validity were examined using Mann-Whitney U test and Spearman correlation (α = .05), respectively. Results: Responses from 400 participants (mean age 18.8 ± 1.5 years; 52.3% women) were evaluated. Pain-related (WPT) and all (WAT) TMDs were present in 8.5% and 17.3% of the sample, respectively. The PSS-8 exhibited good internal consistency (α = 0.82) and sound known-groups validity, with the WPT/WAT groups having significantly higher PSS-8 scores than those without TMDs. Good concurrent and convergent validity were also observed, with moderate to strong correlations with the PHQ-15 (rs = 0.97) and DASS-21 scores (rs = 0.48 to 0.60). Correlations with the TPS and SFAI scores were weaker (rs = 0.28 to 0.34). Conclusion: The PSS-8 presented good psychometric properties and performed similarly to the PHQ-15. It holds promise as the “de facto” shortened version of the PHQ-15 for TMDs and related work.


Keywords

pain measurement; reliability and validity; reproducibility of results; somatic symptoms; temporomandibular joint disorders


Cite and Share

Adrian Ujin Yap,Darren Zong Ru Lee,Sharon Hui Xuan Tan. The Physical Symptom Scale-8: Psychometric Characteristics of a Short-Form Version of the PHQ-15 and its Use in TMD-Related Assessment and Research. Journal of Oral & Facial Pain and Headache. 2023. 37(3);159-165.

References

1. List T, Jensen RH. Temporomandibular disorders: Old ideas and new concepts. Cephalalgia 2017;37:692–704.

2. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporoman-dibular disorders: A systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:453–462.

3. Ryan J, Akhter R, Hassan N, Hilton G, Wickham J, Ibaragi S. Epidemiology of temporomandibular disorder in the general population: A systematic review. Adv Dent Oral Health 2019;10:555787.

4. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187–192.

5. Slade GD, Fillingim RB, Sanders AE, et al. Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: Implications and future directions. J Pain 2013;14(12 suppl):T116–T124.

6. Chisnoiu AM, Picos AM, Popa S, et al. Factors involved in the etiology of temporomandibular disorders—A literature review. Clujul Med 2015;88:473–478.

7. Yap AU, Zhang M-J, Cao Y, Lei J, Fu K-Y. Comparison of psychological states and oral health-related quality of life of pa-tients with differing severity of temporomandibular disorders. J Oral Rehabil 2022;49:177–185.

8. De la Torre Canales G, Câmara-Souza MB, Muñoz Lora VRM, et al. Prevalence of psychosocial impairment in temporoman-dibular disorder patients: A systematic review. J Oral Rehabil 2018;45:881–889.

9. Fantoni F, Salvetti G, Manfredini D, Bosco M. Current concepts on the functional somatic syndromes and temporomandibular disorders. Stomatologija 2007;9:3–9.

10. Robinson LJ, Durham J, Newton JL. A systematic review of the comorbidity between temporomandibular disorders and chronic fatigue syndrome. J Oral Rehabil 2016;43:306–316.

11. Ayouni I, Chebbi R, Hela Z, Dhidah M. Comorbidity between fibromyalgia and temporomandibular disorders: A systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;128:33–42.

12. Lipowski ZJ. Somatization: The concept and its clinical application. Am J Psychiatry 1988;145:1358–1368.

13. Choi E, Chentsova-Dutton Y, Parrott WG. The effectiveness of somatization in communicating distress in Korean and American cultural contexts. Front Psychol 2016;7:383.

14. Dreher A, Hahn E, Diefenbacher A, et al. Cultural differences in symptom representation for depression and somatization mea-sured by the PHQ between Vietnamese and German psychiatric outpatients. J Psychosom Res 2017;102:71–77.

15. Grover S, Ghosh A. Somatic symptom and related disorders in Asians and Asian Americans. Asian J Psychiatr 2014;7:77–79.

16. Yap AU, Sultana R, Natu VP. Somatic and temporomandibular disorder symptoms—Idioms of psychological distress in Southeast Asian youths. Cranio 2021;1–8.

17. Cork C, Kaiser BN, White RG. The integration of idioms of distress into mental health assessments and interventions: A systematic review. Glob Ment Health (Camb) 2019;6:e7.

18. Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–266.

19. Zijlema WL, Stolk RP, Löwe B, et al. How to assess common somatic symptoms in large-scale studies: A systematic review of questionnaires. J Psychosom Res 2013;74:459–468.

20. Kroenke K, Spitzer RL, Williams JBW, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. Gen Hosp Psychiatry 2010;32:345–359.

21. Oyama O, Paltoo C, Greengold J. Somatoform disorders. Am Fam Physician 2007;76:1333–1338.

22. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: Recommendations of the international RDC/TMD consortium network and orofacial pain special interest group. J Oral Facial Pain Headache 2014;28:6–27.

23. Sahlqvist S, Song Y, Bull F, et al. Effect of questionnaire length, personalisation and reminder type on response rate to a complex postal survey: Randomised controlled trial. BMC Med Res Methodol 2011;11:62.

24. Rolstad S, Adler J, Rydén A. Response burden and question-naire length: Is shorter better? A review and meta-analysis. Value Health 2011;14:1101–1108.

25. Gierk B, Kohlmann S, Kroenke K, et al. The somatic symptom scale-8 (SSS-8): A brief measure of somatic symptom burden. JAMA Intern Med 2014;174:399–407.

26. Narrow WE, Clarke DE, Kuramoto SJ, et al. DSM-5 field trials in the United States and Canada, Part III: Development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry 2013;170:71–82.

27. Gonzalez YM, Schiffman E, Gordon SM, et al. Development of a brief and effective temporomandibular disorder pain screening questionnaire: Reliability and validity. J Am Dent Assoc 2011;142:1183–1191.

28. Pires PF, de Castro EM, Pelai EB, de Arruda ABC, Rodrigues-Bigaton D. Analysis of the accuracy and reliability of the Short-Form Fonseca Anamnestic Index in the diagnosis of myogenous temporomandibular disorder in women. Braz J Phys Ther 2018;22:276–282.

29. Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales, ed 2. Psychology Foundation of Australia,1995.

30. Yap AU, Zhang M-J, Lei J, Fu K-Y. Diagnostic accuracy of the short-form Fonseca anamnestic index in relation to the diagnostic criteria for temporomandibular disorders. J Prosthet Dent 2022;128:977–983.

31. Rodrigues-Bigaton D, de Castro EM, Pires PF. Factor and Rasch analysis of the Fonseca Anamnestic Index for the diag-nosis of myogenous temporomandibular disorder. Braz J Phys Ther 2017;21:120–126.

32. Lee J, Lee E-H, Moon SH. Systematic review of the measurement properties of the depression anxiety stress scales-21 by applying updated COSMIN methodology. Qual Life Res 2019;28:2325–2339.

33. Henry JD, Crawford JR. The short-form version of the depres-

sion anxiety stress scales (DASS-21): Construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005;44:227–239.

34. Cunha CM, de Almeida Neto OP, Stackfleth R. Principais métodos de avaliação psicométrica da confiabilidade de instrumentos de medida [in Portuguese]. Rev Aten Saúde 2016;14:98–103.

35. Dancey CP, Reidy J. Statistics Without Maths for Psychology, ed 7. London: Pearson; 2017.

36. Peixoto KO, de Resende CMBM, de Almeida EO, et al. Association of sleep quality and psychological aspects with reports of bruxism and TMD in Brazilian dentists during the COVID-19 pandemic. J Appl Oral Sci 2021;29:e20201089.

37. Johnson KA, Gordon CJ, Grunstein RR. Somatic symptoms are associated with insomnia disorder but not obstructive sleep apnoea or hypersomnolence in traumatic brain injury. NeuroRehabilitation 2019;45:409–418.

38. Zanon C, Brenner RE, Baptista MN, et al. Examining the dimensionality, reliability, and invariance of the Depression, Anxiety, and Stress Scale-21 (DASS-21) across eight countries. Assessment 2021;28:1531–1544.

39. Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: The OPPERA prospective cohort study. J Pain 2013;14(12 suppl):T75–T90.

40. Stauder A, Witthöft M, Köteles F. Validation of the Hungarian PHQ-15. A latent variable approach. Ideggyogy Sz 2021;74:183–190.

41. Zhang L, Fritzsche K, Liu Y, et al. Validation of the Chinese version of the PHQ-15 in a tertiary hospital. BMC Psychiatry 2016;16:89.

42. Tietjen GE, Brandes JL, Digre KB, et al. High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology 2007;68:134–140.

43. Toussaint A, Kroenke K, Baye F, Lourens S. Comparing the Patient Health Questionnaire-15 and the Somatic Symptom Scale-8 as measures of somatic symptom burden. J Psychosom Res 2017;101:44–50.

44. Turner AI, Smyth N, Hall SJ, et al. Psychological stress reactivity and future health and disease outcomes: A systematic review of prospective evidence. Psychoneuroendocrinology 2020;114:104599.

45. Fincham JE. Response rates and responsiveness for surveys, standards, and the journal. Am J Pharm Educ 2008;72:43.

46. Morton SMB, Bandara DK, Robinson EM, Carr PEA. In the 21st century, what is an acceptable response rate? Aust N Z J Public Health 2012;36:106–108.

47. Althubaiti A. Information bias in health research: Definition, pitfalls, and adjustment methods. J Multidiscip Healthc 2016;9:211–217.



Abstracted / indexed in

Science Citation Index (SCI)

Science Citation Index Expanded (SCIE)

BIOSIS Previews

Scopus

Cumulative Index to Nursing and Allied Health Literature (CINAHL)

Submission Turnaround Time

Conferences

Top